Skip to main content
LobbyMap

Allergan plc

Pharmaceutical & Health Products · Lobbying Client

C
Influence Score
57/100
Moderate Influence
$8.0M
Total Lobby Spend
4
Policy Issues
5
Lobbyists
2
Revolving Door

Allergan plc reported $8.0 million in federal lobbying expenditures (2020-2024) as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

National Science Foundation
Dept of Education
Federal Aviation Administration
Securities & Exchange Commission
Dept of Agriculture
U.S. Senate
Federal Energy Regulatory Commission

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2024 Oct-DecSquire Patton Boggs
MEDPHAHCR+1
3$403K
2024 Jul-SepVan Scoyoc Associates
HCRPHAGOV+1
4$404K
2024 Apr-JunCapitol Counsel
MEDPHAGOV+1
4$388K
2024 Jan-MarBrownstein Hyatt Farber Schreck
PHAGOV
2$284K
2023 Oct-DecTarplin, Downs & Young
HCRGOVMED+1
4$383K
2023 Jul-SepSubject Matter
HCRPHAMED
1$338K
2023 Apr-JunSquire Patton Boggs
HCRPHAGOV+1
4$461K
2023 Jan-MarK&L Gates
PHAGOV
4$386K

Allergan plc Lobbying FAQ

Allergan plc has spent $8.0M on federal lobbying across 4 policy areas. This includes spending on registered lobbyists and direct government contacts.

Allergan plc lobbies on 4 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.

Allergan plc has an Influence Score of 57/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Allergan plc employs 5 registered lobbyists, of whom 2 have revolving door connections — meaning they previously held government positions before becoming lobbyists.

Allergan plc has contacted 7 government entities as part of their lobbying activities, including National Science Foundation, Dept of Education, Federal Aviation Administration.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.